← All investors

Firm & fund profile / Sourced portfolio

NVentures

Tracked participation in 22 Atlas companies, with 1 explicitly attributed lead.

Firm website ↗

22portfolio companies

26round participations

1lead positions

$50Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jun 2024Twelve LabsSeries A$50M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

OOpenRouter$1.3BMay 2026 → May 20261 roundParticipant—

OMOrbital Materials—Oct 2024 → May 20262 roundsParticipant—

LLegora$5.6BApr 2026 → Apr 20261 roundParticipant—

OOdyssey—Feb 2026 → Feb 20261 roundParticipant—

WWaabi—Jan 2026 → Jan 20261 roundParticipant—

SSynthesia$4BJan 2026 → Jan 20261 roundParticipant—

LLovable$6.6BDec 2025 → Dec 20251 roundParticipant—

PPolyAI$750MMay 2024 → Dec 20252 roundsParticipant—

RTRelation TherapeuticsScienceRelation Therapeutics is an AI-driven biopharmaceutical company building a biology-first, lab-and-computation “loop”…$116MraisedRecent roundsSeed (additional investment) · Dec 2025$26M · Data Collective Venture Capital (DCVC), DCVC +2Strategic collaboration (includes equity investment) · Dec 2025$55M · NovartisSeed (new seed financing) · Mar 2024$35M · led by Data Collective Venture Capital (DCVC)Relation Therapeutics—Mar 2024 → Dec 20252 roundsParticipant—

SSuno$2.5BNov 2025 → Nov 20251 roundParticipant—

LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila Sciences$1.3BOct 2025 → Oct 20251 roundParticipant—

CCuspAI$520MSep 2025 → Sep 20252 roundsParticipant—

FAField AIPhysical AIFieldAI is a physical-AI company building “one brain” autonomy software intended to help third-party robots (and…$2Bvaluation$587MraisedRecent roundsSeries A / Series A-1 (two consecutive rounds disclosed together) · Aug 2025$405M · led by Bezos Expeditions, Prysm +1earlier component of the two consecutive rounds (details limited)$91MSeries A-1 / initial priced venture round (amount disclosed as initial portion of 2025 total)$91M · Gates Frontier, SamsungField AI$2BAug 2025 → Aug 20251 roundParticipant—

RARadical AI—Jul 2025 → Jul 20251 roundParticipant—

ARAgility RoboticsPhysical AIAgility Robotics (agilityrobotics.com) builds Digit, a humanoid robot designed to perform logistics and…$2.5Bvaluation$1.2BraisedRecent roundsBusiness combination / SPAC transaction (expected) — common stock PIPE committed · Jun 2026$200M · led by FoxconnSeries C (reported close) · 2025-03-XX$400M · Amazon Industrial Innovation Fund, DCVC +5Series C · Mar 2025$400M · Amazon Industrial Innovation Fund, DCVC +5Agility Robotics$2.1B2025-03-XX → 2025-03-XX1 roundParticipant—

AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10Abridge—Feb 2025 → Feb 20251 roundParticipant—

GTGenesis Therapeutics—Nov 2024 → Nov 20241 roundParticipant—

TTTerray Therapeutics—Oct 2024 → Oct 20241 roundParticipant—

EEvolutionaryScale—Jun 2024 → Jun 20241 roundParticipant—

TLTwelve Labs—Jun 2024 → Jun 20241 round1 led—

GGenerate:BiomedicinesScienceGenerate:Biomedicines (Nasdaq: GENB) is a clinical-stage therapeutics company focused on “generative biology”: a…$1.1BraisedRecent roundsIPO (initial public offering) · Feb 2026$400M · Cantor Fitzgerald & Co., Goldman Sachs & Co. LLC +3Series C · Sep 2023$273M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +10Series B · Nov 2021$370M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +8Generate:Biomedicines—Sep 2023 → Sep 20231 roundParticipant—

BRBasecamp Research—— → —1 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

May 28, 2026OOpenRouterSeries B$113M$1.3BParticipant